Warning: mysqli_query(): (HY000/1030): Got error 28 from storage engine in /home/mmahotstuff3/public_html/wp-includes/wp-db.php on line 1924
Could Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Change Direction After More Shorts? - Money Making Articles Hot Stuff

Could Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Change Direction After More Shorts?

October 13, 2018 - By Michael Collier

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Logo

The stock of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) registered an increase of 148.82% in short interest. TNXP’s total short interest was 514,800 shares in October as published by FINRA. Its up 148.82% from 206,900 shares, reported previously. With 1.71M shares average volume, it will take short sellers 0 days to cover their TNXP’s short positions.

It closed at $0.55 lastly. It is down 80.47% since October 13, 2017 and is downtrending. It has underperformed by 96.09% the S&P500.

Tonix Pharmaceuticals Holding Corp. engages in developing pharmaceutical and biological products to address public health challenges. The company has market cap of $5.51 million. The Company’s lead product candidate, TNX-102 SL or Tonmya, designed as a bedtime treatment for posttraumatic stress disorder , which is in Phase 3 study in the military-related PTSD population. It currently has negative earnings. The firm is also developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (investigational new drug) application stage, designed as a daytime treatment for posttraumatic stress disorder (PTSD); and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Ratings Coverage

Among 2 analysts covering Tonix Pharmaceuticals (NASDAQ:TNXP), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Tonix Pharmaceuticals had 3 analyst reports since June 6, 2018 according to SRatingsIntel. The rating was downgraded by Roth Capital to “Neutral” on Friday, July 27. As per Friday, July 27, the company rating was downgraded by FBR Capital.

More news for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) were recently published by: Globenewswire.com, which released: “Tonix Pharmaceuticals to Present at the MicroCap Conference” on September 26, 2018. Benzinga.com‘s article titled: “The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares” and published on September 18, 2018 is yet another important article.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:



Warning: mysqli_query(): (HY000/1030): Got error 28 from storage engine in /home/mmahotstuff3/public_html/wp-includes/wp-db.php on line 1924
>